These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14633624)

  • 21. β-catenin in the alveolar epithelium protects from lung fibrosis after intratracheal bleomycin.
    Tanjore H; Degryse AL; Crossno PF; Xu XC; McConaha ME; Jones BR; Polosukhin VV; Bryant AJ; Cheng DS; Newcomb DC; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
    Am J Respir Crit Care Med; 2013 Mar; 187(6):630-9. PubMed ID: 23306543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice.
    Waseda Y; Yasui M; Nishizawa Y; Inuzuka K; Takato H; Ichikawa Y; Tagami A; Fujimura M; Nakao S
    Respir Res; 2008 May; 9(1):43. PubMed ID: 18500976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of suramin on bleomycin-induced lung injury.
    Lossos IS; Izbicki G; Or R; Goldstein RH; Breuer R
    Life Sci; 2000 Oct; 67(23):2873-81. PubMed ID: 11106002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human recombinant interferon-alpha2a and interferon-alphaA/D have different effects on bleomycin-induced lung injury.
    Berkman N; Kremer S; Or R; Lossos IS; Christensen TG; Goldstein RH; Breuer R
    Respiration; 2001; 68(2):169-77. PubMed ID: 11287832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abatement of bleomycin-induced pulmonary injury by cell-impermeable inhibitor of phospholipase A2.
    Breuer R; Lossos IS; Or R; Krymsky M; Dagan A; Yedgar S
    Life Sci; 1995; 57(16):PL237-40. PubMed ID: 7564888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise Improves Lung Inflammation, but Not Lung Remodeling and Mechanics in a Model of Bleomycin-Induced Lung Fibrosis.
    El-Mafarjeh E; Martins GHC; Probst JJ; Santos-Dias A; Oliveira-Junior MC; de Barros MP; de Oliveira LVF; de Andrade LD; da Palma RK; Moraes-Ferreira R; de Camargo Hizume-Kunzler D; Bachi ALL; Vieira RP
    Oxid Med Cell Longev; 2020; 2020():4302608. PubMed ID: 33123311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Perindopril and losartan attenuate bleomycin A5-induced pulmonary fibrosis in rats].
    Meng Y; Meng Y; Li X; Cai SX; Tong WC; Cheng YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):919-24. PubMed ID: 18583228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies.
    Kilinç C; Ozcan O; Karaöz E; Sunguroğlu K; Kutluay T; Karaca L
    J Basic Clin Physiol Pharmacol; 1993; 4(3):249-69. PubMed ID: 8679519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleomycin-Induced Neonatal Lung Injury Requires the Autocrine Pulmonary Angiotensin System.
    Abdelwahab A; Gopallawa I; Piasecki CC; Gewolb IH; Uhal BD
    Jacobs J Pulmonol; 2016 Sep; 2(3):. PubMed ID: 27928554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis-dependent acute pulmonary injury after intratracheal instillation of angiotensin II.
    Zhuang JJ; Li XP; Uhal BD; Yian KR
    Sheng Li Xue Bao; 2008 Dec; 60(6):715-22. PubMed ID: 19082426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential role for cathepsin D in bleomycin-induced apoptosis of alveolar epithelial cells.
    Li X; Rayford H; Shu R; Zhuang J; Uhal BD
    Am J Physiol Lung Cell Mol Physiol; 2004 Jul; 287(1):L46-51. PubMed ID: 14977632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.
    Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
    Eur J Clin Invest; 2013 Mar; 43(3):309-15. PubMed ID: 23320620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters.
    Ben Yehuda A; Lossos IS; Or R; Ben Chetrit E; Goldstein RH; Conner MW; Breuer R
    Pulm Pharmacol Ther; 1997; 10(1):61-5. PubMed ID: 9344834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A upmodulates bleomycin-induced pulmonary fibrosis in BALB/c mice.
    Lossos IS; Or R; Ginzburg V; Christensen TG; Mashriki Y; Breuer R
    Respiration; 2002; 69(4):344-9. PubMed ID: 12169749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redox imbalance and pulmonary function in bleomycin-induced fibrosis in C57BL/6, DBA/2, and BALB/c mice.
    Santos-Silva MA; Pires KM; Trajano ET; Martins V; Nesi RT; Benjamin CF; Caetano MS; Sternberg C; Machado MN; Zin WA; Valença SS; Porto LC
    Toxicol Pathol; 2012 Jul; 40(5):731-41. PubMed ID: 22549973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis.
    Song JS; Kang CM; Rhee CK; Yoon HK; Kim YK; Moon HS; Park SH
    Exp Lung Res; 2009 Dec; 35(10):817-29. PubMed ID: 19995276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
    Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
    Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
    Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
    Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local activation of the pulmonary extravascular angiotensin system induces epithelial apoptosis and lung fibrosis.
    Li X; Zhuang J; Uhal BD
    J Lung Pulm Respir Res; 2018; 5(6):192-200. PubMed ID: 32524006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
    De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
    Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.